94 related articles for article (PubMed ID: 24319047)
21. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter.
Remzi M; Ozsoy M; Klingler HC; Susani M; Waldert M; Seitz C; Schmidbauer J; Marberger M
J Urol; 2006 Sep; 176(3):896-9. PubMed ID: 16890647
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of clinicopathological features and prognosis in 68 patients with chromophobe renal cell carcinoma].
Huang JW; Zhang J; Dong BJ; Kong W; Niu SX; Chen YH; Xue W; Liu DM; Huang YR
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):510-3. PubMed ID: 22967469
[TBL] [Abstract][Full Text] [Related]
23. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma.
Van Poppel H; Vandendriessche H; Boel K; Mertens V; Goethuys H; Haustermans K; Van Damme B; Baert L
J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of capsular invasion without perinephric fat infiltration in localized renal cell carcinoma.
Jeong IG; Jeong CW; Hong SK; Kwak C; Lee E; Lee SE
Urology; 2006 Apr; 67(4):709-12. PubMed ID: 16566981
[TBL] [Abstract][Full Text] [Related]
25. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
26. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience.
Klatte T; Patard JJ; Goel RH; Kleid MD; Guille F; Lobel B; Abbou CC; De La Taille A; Tostain J; Cindolo L; Altieri V; Ficarra V; Artibani W; Prayer-Galetti T; Allhoff EP; Schips L; Zigeuner R; Figlin RA; Kabbinavar FF; Pantuck AJ; Belldegrun AS; Lam JS
J Urol; 2007 Jul; 178(1):35-40; discussion 40. PubMed ID: 17521678
[TBL] [Abstract][Full Text] [Related]
28. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.
Lane BR; Babineau D; Kattan MW; Novick AC; Gill IS; Zhou M; Weight CJ; Campbell SC
J Urol; 2007 Aug; 178(2):429-34. PubMed ID: 17561141
[TBL] [Abstract][Full Text] [Related]
29. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
[TBL] [Abstract][Full Text] [Related]
30. Reevaluation of renal cell carcinoma and perirenal fat invasion only.
Jeon HG; Jeong IG; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2009 Nov; 182(5):2137-43. PubMed ID: 19758661
[TBL] [Abstract][Full Text] [Related]
31. Staging refinements in renal cell carcinoma.
Howard GE; Wood CG
Curr Opin Urol; 2006 Sep; 16(5):317-20. PubMed ID: 16905974
[TBL] [Abstract][Full Text] [Related]
32. Analysis of renal cell carcinoma with subdiaphragmatic macroscopic venous invasion (T3b).
Klaver S; Joniau S; Suy R; Oyen R; Van Poppel H
BJU Int; 2008 Feb; 101(4):444-9. PubMed ID: 18021278
[TBL] [Abstract][Full Text] [Related]
33. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
34. The role of percutaneous needle biopsy in differentiation of renal tumors.
Izumi K; Narimoto K; Sugimoto K; Kobori Y; Maeda Y; Mizokami A; Koh E; Yamada T; Yano S; Namiki M
Jpn J Clin Oncol; 2010 Nov; 40(11):1081-6. PubMed ID: 20601495
[TBL] [Abstract][Full Text] [Related]
35. [Impact of tumor size on long-term survival of patients with organ-confined renal cell cancer].
Merseburger AS; Wegener G; Horstmann M; Oelke M; Zumbrägel A; Bokemeyer C; Kollmannsberger C; Jonas U; Stenzl A; Kuczyk M
Aktuelle Urol; 2003 Dec; 34(7):469-74. PubMed ID: 14655083
[TBL] [Abstract][Full Text] [Related]
36. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
[TBL] [Abstract][Full Text] [Related]
37. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma.
Suzuki K; Mizuno R; Mikami S; Tanaka N; Kanao K; Kikuchi E; Miyajima A; Nakagawa K; Oya M
Jpn J Clin Oncol; 2012 Sep; 42(9):831-5. PubMed ID: 22811408
[TBL] [Abstract][Full Text] [Related]
40. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
